Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke

被引:70
作者
Cui, Xu [1 ]
Chopp, Michael [1 ,4 ]
Zacharek, Alex [1 ]
Roberts, Cynthia [1 ]
Lu, Mei [2 ]
Savant-Bhonsale, Smita [3 ]
Chen, Jieli [1 ]
机构
[1] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA
[2] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA
[3] Theradigm Inc, Dept Neurobiol, Baltimore, MD 21227 USA
[4] Oakland Univ, Dept Phys, Rochester, MI 48309 USA
关键词
Bone marrow stromal cell; Simvastatin; Arteriogenesis; Angiogenesis; Stroke; MARROW STROMAL CELLS; ARTERY GROWTH ARTERIOGENESIS; ENDOTHELIAL PROGENITOR CELLS; MESENCHYMAL STEM-CELLS; NITRIC-OXIDE DONOR; IN-VIVO; MYOCARDIAL-INFARCTION; PARACRINE MECHANISMS; CEREBRAL-ISCHEMIA; ANGIOGENESIS;
D O I
10.1016/j.nbd.2009.06.012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We investigated the additive therapeutic effect of the combination treatment of stroke with sub-therapeutic doses of Simvastatin, a HMG-CoA reductase inhibitor, and bone marrow stromal cells (BMSCs). Rats were administered Simvastatin (0.5 mg/kg), BMSCs (1x10(6)) or combination of Simvastatin and BMSCs starting at 24 h after stroke. Combination treatment significantly improved neurological outcome, enhanced angiogenesis and arteriogenesis, and increased the number of engrafted-BMSCs in the ischemic brain. The number of engrafted-BMSCs and arteriogenesis was significantly correlated with functional outcome. Simvastatin significantly increased stromal cell-derived factor-1 (SDF1) expression in the ischemic brain and chemokine (CXC motif) receptor-4 (CXCR4) in BMSCs, and increased BMSC migration to RBMECs and astrocytes. Combination treatment of stroke upregulates the SDF1/CXCR4 axis and enhances BMSC migration into the ischemic brain, amplifies arteriogenesis and angiogenesis, and improves functional outcome after stroke. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:35 / 41
页数:7
相关论文
共 42 条
[1]   Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo [J].
Al-Khaldi, A ;
Eliopoulos, N ;
Martineau, D ;
Lejeune, L ;
Lachapelle, K ;
Galipeau, J .
GENE THERAPY, 2003, 10 (08) :621-629
[2]   Protective effects of statin involving both eNOS and tPA in focal cerebral ischemia [J].
Asahi, M ;
Huang, ZH ;
Thomas, S ;
Yoshimura, S ;
Sumii, T ;
Mori, T ;
Qiu, JH ;
Amin-Hanjani, S ;
Huang, PL ;
Liao, JK ;
Lo, EH ;
Moskowitz, MA .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2005, 25 (06) :722-729
[3]   The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation [J].
Bhakta, Shyam ;
Hong, Ping ;
Koc, Omer .
CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2006, 7 (01) :19-24
[4]   Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats [J].
Borlongan, CV ;
Lind, JG ;
Dillon-Carter, O ;
Yu, GL ;
Hadman, M ;
Cheng, C ;
Carroll, J ;
Hess, DC .
BRAIN RESEARCH, 2004, 1010 (1-2) :108-116
[5]  
Buschmann I, 2000, J PATHOL, V190, P338, DOI 10.1002/(SICI)1096-9896(200002)190:3<338::AID-PATH594>3.0.CO
[6]  
2-7
[7]   Why are MSCs therapeutic? New data: new insight [J].
Caplan, Al .
JOURNAL OF PATHOLOGY, 2009, 217 (02) :318-324
[8]   Mechanisms of angiogenesis and arteriogenesis [J].
Carmeliet, P .
NATURE MEDICINE, 2000, 6 (04) :389-395
[9]   Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia [J].
Chade, Alejandro R. ;
Zhu, Xiangyang ;
Mushin, Oren P. ;
Napoli, Claudio ;
Lerman, Amir ;
Lerman, Lilach O. .
FASEB JOURNAL, 2006, 20 (10) :1706-+
[10]  
CHEN J, J CELL MOL IN PRESS